Amarin Corp Plcuk (AMRN) Share-based Compensation (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Share-based Compensation of $2.3 million for Q1 2026, down 46.13% year-over-year from $4.3 million in Q1 2025, and up 44.33% quarter-over-quarter from $1.6 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Share-based Compensation (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Share-based Compensation data on file, last reported at $2.3 million in Q1 2026.

  • Share-based Compensation for Q1 2026 came in at $2.3 million, down 46.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.9 million (down 28.98% YoY), and the FY2025 annual result was $13.9 million, down 21.28% from the prior year.
  • Share-based Compensation improved to $2.3 million in Q1 2026 per AMRN's latest filing, from $1.6 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $8.6 million in Q2 2022 and troughed at $1.6 million in Q4 2025.
  • A 5-year average of $4.5 million and a median of $4.6 million in 2023 frame the typical range for Share-based Compensation.
  • The sharpest annual moves came in 2022 and 2023: Share-based Compensation soared 248.77% in 2022, then tumbled 78.78% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $6.6 million in 2022, then declined by 29.72% to $4.6 million in 2023, then dropped by 26.79% to $3.4 million in 2024, then slumped by 52.53% to $1.6 million in 2025, then surged by 44.33% to $2.3 million in 2026.
  • Business Quant data shows AMRN's Share-based Compensation at $2.3 million in Q1 2026, $1.6 million in Q4 2025, and $2.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 161.00 Mn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 300.00 Mn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 444.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 185.00 Mn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 75.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 218.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 272.00 Mn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 146.00 Mn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn 2.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.33 Mn
Mar 31, 2026 2.33 Mn
Dec 31, 2025 1.62 Mn
Dec 31, 2025 1.62 Mn
Sep 30, 2025 1.96 Mn
Sep 30, 2025 1.96 Mn
Jun 30, 2025 6.04 Mn
Jun 30, 2025 6.04 Mn
Mar 31, 2025 4.33 Mn
Mar 31, 2025 4.33 Mn
Dec 31, 2024 3.40 Mn
Dec 31, 2024 3.40 Mn
Sep 30, 2024 4.70 Mn
Sep 30, 2024 4.70 Mn
Jun 30, 2024 4.39 Mn
Jun 30, 2024 4.39 Mn
Mar 31, 2024 5.22 Mn
Mar 31, 2024 5.22 Mn
Dec 31, 2023 4.65 Mn
Dec 31, 2023 4.65 Mn